This Week in Psychedelics - 11.12.21

Cannabis

  • Top Mexican Senator Says There’s Agreement To Prioritize Marijuana Legalization Legislation This Session (Marijuana Moment)

  • Germany’s Next Coalition Nears Deal on Legalizing Cannabis (Bloomberg)

  • Texas judge allows legal sale of delta-8 products—for now (Leafly)

  • New York adopts final rules banning delta-8 THC, smokable hemp (HempToday)

  • Another Poll Shows Majority Support For Marijuana Legalization, Including Most Republicans (Marijuana Moment)

  • Herbal Supplement Giant To Enter THC, Psychedelics Industries, Seeking To Become First Household Brand To Do So (Forbes)

  • This MMA fighter is taking on cannabis stigma in sports (Leafly)

  • What Happens When You Mix Cannabis With Psychedelics? (IFLScience)

  • Marijuana Legalization In Canada Did Not Result In Increased Traffic Injuries, Study Finds (Marijuana Moment)

  • Medical Cannabis for Epilepsy - Research Summary and Recommendations (Drug Science)

  • Medical Cannabis Sales Finally Set to Begin in West Virginia (NORML)

  • South Dakota Marijuana Activists Delay Legalization Signature Delivery After Missing Initial Deadline (Marijuana Moment)

  • Cannabis requires more water than commodity crops, researchers say (Marijuana Business Times)

LSD

  • Sweden Experimenting With Rats on LSD to Cure Depression, Addiction (Sputnik News)

  • How Likely Are Bad Trips and Flashbacks from LSD? (Psychedelic Science Review)

  • Blackhawk Growth's MindBio Therapeutics Completes Safety Milestone in its Phase 1 Clinical Trials (Yahoo!)

Magic Mushrooms

  • Largest psychedelic therapy trial to date delivers mixed results (New Atlas)

  • Nonprofit Hosts Canada’s First Legal Psilocybin Group Therapy (Truffle Report)

  • Australian Therapists to Be Given Psilocybin to Better Understand Their Patients (VICE)

  • Denver City Council Considers Expanding Psilocybin Decriminalization (Marijuana Moment)

  • Psilocybin therapy boosts cognitive and neural flexibility in depressed patients, study finds (PsyPost)

  • A Look at Connecticut’s Psilocybin Study Workgroup (Truffle Report)

MDMA

  • Doctor takes bid to treat patient with MDMA to court, in first case of its kind in Australia (Australian Broadcasting Corporation)

  • The Story Behind the 'First Ever Ecstasy Song' (VICE)

  • Expert: MDMA Is Very Likely to Be FDA-Approved for PTSD by the End of 2023 (Pharmacy Times)

  • Veteran Who Cured PTSD with MDMA-Assisted Therapy Wows NBC ‘Today’ Show Anchors (Psychedelic Spotlight)

  • Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials (PR Newswire)

Ayahuasca

  • A cancer doctor said doing ayahuasca saved his marriage and relationship with his 2 young children (Yahoo!)

Novel Psychoactive Substances

  • Pre-Clinical Data Shows Cybin’s Novel Analog Could Have Advantages Over Psilocybin (Forbes)

  • Forgotten Psychedelics: What Is 2C-B? (Psychedelic Spotlight)

Ketamine

  • Baby Girl Died From 'Acute Ketamine Intoxication,' and Prosecutors Charge Washington Father With Murder (The Daily Chronicle)

  • Single Infusion of Ketamine Rapidly Reduces Suicidal Thoughts (Medscape)

  • Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

  • Psychedelics Wellness Scores Big Win With New Mainstream Deal (Forbes)

Miscellaneous

  • DEA Boosts Psilocybin, MDMA And DMT Production Levels Again In Final Quotas For 2021 (Marijuana Moment)

  • New Website Details Abuse Allegations Against German Psychedelic Practitioners (Psymposia)

  • Big Tech's Psychedelics Grift (WIRED)

  • Prosecutors seek 4+ years in prison for 'QAnon Shaman' in attempt to set example (CNN)

  • Will the magic of psychedelics transform psychiatry? (The Guardian)

  • Veterans Have Become Unlikely Lobbyists in Push to Legalize Psychedelic Drugs (The New York Times)

  • Psychedelics Could Become Extractive Capitalism—Unless We Hold Stakeholders Accountable (DoubleBlind)

  • Tim Ferriss Funds Fellowships for Journalists Reporting On Psychedelics (Lucid News)

  • 6 Ways the Psychedelic Space Can Divest From Whiteness (DoubleBlind)

  • Is Microdosing a Placebo? Here’s what our Head of Research Says (The Third Wave)

  • Countries not adequately addressing illegal drug use: Experts (The Straits Times)

  • Startup offers psychedelic-assisted mental wellness therapies (Axios)

  • The Masters of Bad Trips (Psymposia)

  • Monash University announces establishment of the Neuromedicines Discovery Centre to Focus on Psychedelic-Assisted Therapies for the Treatment of Key Classes of Mental Illness (Mind Medicine Australia)

  • Psychedelic Company Lists on NASDAQ as ‘DRUG’ (High Times)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.